MedTrace Logo

ResQ Trial: Impact of an ITD and Active Compression Decompression CPR on Survival From Out-of-Hospital Cardiac Arrest

NCT00189423 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1653

Last updated 2017-12-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether performing active compression decompression cardiopulmonary resuscitation (ACD-CPR) with an impedance threshold device (ITD) compared to conventional standard cardiopulmonary resuscitation (S-CPR) will impact the neurologic recovery and survival to hospital discharge following out-of-hospital cardiac arrest.

Conditions

  • Heart Arrest
  • Death, Sudden, Cardiac
  • Cardiopulmonary Resuscitation
  • Cardiac Arrest

Interventions

DEVICE

Use of an impedance threshold device (ITD) during the performance of active compression decompression CPR (ACD-CPR)

The ITD selectively prevents the influx of unnecessary respiratory gases into the patient during the chest wall recoil phase of CPR. The ResQPump, a hand-held device containing a suction cup, attaches to the chest and actively compresses and actively re-expands the chest during the performance of CPR.

PROCEDURE

Standard cardiopulmonary resuscitation (S-CPR)

Conventional standard cardiopulmonary resuscitation (S-CPR)

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Advanced Circulatory Systems

    lead INDUSTRY

Principal Investigators

  • Keith G. Lurie, MD · Advanced Circulatory Systems

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00189423 on ClinicalTrials.gov